A review of hand-held Electrocardiogram (ECG) recording devices

Abstract

Funding AcknowledgementsType of funding sources: Public hospital(s). Main funding source(s): St Barts NHS TrustIntroductionThe advent of portable hand-held devices to record an electrocardiogram (ECG) in-clinic, has the potential to streamline patient assessment in many clinical environments. These ECG technologies are able to record one to six lead ECGs and enable rapid responses to clinical situations. These devices may also have a role in reducing interdepartmental movement of patients during the COVID-19 pandemic, by facilitating a one-stop shop for clinical evaluation. However despite their benefit, they can be more prone to artefact than a 12-lead ECG.PurposeTo describe the currently available hand-held ECG technologies, their ease of use and diagnostic accuracy for rhythm assessment.MethodAn online review was conducted to identify new ECG technologies. Clinical colleagues were also surveyed for recommendations with respect to specifications, availability of alternative products, and informed of the inclusion /exclusion criteria. The review included devices which had built-in abnormal rhythm notification or display, were cost-effective and easy to use. Devices were automatically excluded if cutaneous skin electrodes were required, no in-built ECG display or notification, additional data transfer required to access ECG data or a high unit cost.ResultsAn initial search uncovered nine devices, with five meeting inclusion /exclusion criteria. These devices were tabulated and compared predefined criteria (See table 1: ECG Technology comparisons). The analysis revealed that all devices utilised two finger placement on their recording electrodes to produce immediate ECG results – no cutaneous ECG application required. The KardiaMobile 6L™ had the largest number of beneficial features, namely multi-channel device, QTc interpretation, rapid diagnosis time and low cost. The intended use of hand-held devices is to detect AF. Four of five devices produced a snapshot ECG for rhythm identification on their display. However, AfibAlert™ devices provided an instant light alert if atrial fibrillation (AF) was detected. Instant check™, Dimitek™ and AfibAlert™ benefit from being complete stand-alone devices. In contrast, KardioMobile devices have a built-in ECG display for instant review however, they require a smart phone or tablet to store and transfer the data. These devices support a reliable internal AF algorithm to obtain a high negative predicted value to safely rule out AF. Frequent premature atrial contractions (PACs) are often difficult to distinguish from AF and can lead to high false-positive rate. Hand-held devices are prone to artefact, however accurate visual assessment able to significantly reduce the amount of ECGs deemed uninterpretable.ConclusionsHand-held ECG technology has potential to become a useful, cost-effective tool during patient consultations, with rapid identification of clinically important arrhythmias. However, limitations exist across providers. A pilot trial of these devices is planned to assess further. Figure.